Leading Innovative Biomedical Measurement Companies Announce Merger

London, ON (July 1, 2011) Transonic Systems Inc. of Ithaca, USA and Scisense Inc. of London, Canada announced today their merger. Scisense manufactures advanced products for blood pressure and cardiac pressure volume assessment, while Transonic is an industry leader in biomedical flow measurement technologies and applications.
The newly formed Transonic-Scisense entity combines two biomedical research innovators, both with strong roots in academia. Their combined expertise will pioneer fully-integrated measurement solutions for the heart and cardiovascular research, clinical diagnostic and cardiovascular surgical markets. The companies’ products are sold and serviced worldwide from local offices in USA, Canada, Europe, Taiwan and Japan.
Moreover, the unique synergies between the two companies will provide:
· Top-rated, proven cardiovascular solutions recognized by scientific researchers for their versatility and comprehensiveness;
· A broad, unified platform of global research solutions for universities, contract researchers and pharmaceutical companies;
· A world-class service and support organization benefiting from the best-practices and infrastructure investments of both companies;
· A stronger pre-clinical and clinical research market presence, including an expanded international footprint;
· Larger revenue streams that will allow continued investment towards innovation.
Cornelis Drost, founder and CEO of Transonic Systems comments, “We are most excited about joining forces with Scisense. Together we will be able to provide our customers with a more comprehensive hemodynamic profile for their measurement armamentaria. We also look forward with anticipation the future innovations that this merger will enable.”
“With this merger we are now able to offer our customers complete and exceptional cardiovascular solutions,” notes Blair Poetschke, president & CEO of Scisense. “It will also enhance our ability to develop revolutionary products in the near future that will further strengthen our global position.”

About Transonic Systems Inc.
R&D Scientist and Engineer Cornelis J. Drost founded Transonic Systems Inc in 1983 after inventing the transit time ultrasound flowmeter for vascular applications -the first ever to measure volume flow in blood vessels- while working as a Senior Research Scientist at Cornell University in Ithaca NY. Transonic quickly became the “Gold Standard” in cardiovascular research, then in surgical applications worldwide. As the company progressed, new flow measurement innovations were added in fields such as Hemodialysis, Critical Care, Surgery, ECMO, and Ventricular Assist Devices, and Transonic has now grown to become recognized as a solutions innovator and applications specialist for all biomedical flow measurement challenges. In addition to its ultrasound transit-time and indicator dilution flow measurements, Transonic offers Laser Doppler Meters for Perfusion Monitoring, and a full range of in implantable biotelemetry measurement solutions via its sister company, Endosomatic Systems, Inc.

Media Contacts:
Blair Poetschke, Scisense Inc.
519-680-7677
www.scisense.com
Miriam Tenorio, Transonic Systems Inc.
607-257-5300
www.transonic.com

About Scisense Inc.
Scisense Inc. specializes in micro-sensing technologies for use in preclinical research. Products include high-fidelity pressure sensors used to measure blood pressure, pressure-volume catheters, and catheters for electrophysiology applications. The company’s head office and manufacturing facilities are located in London, Ontario, Canada. Since its incorporation in 2002, Scisense has focused on contributing to the advancement of research into cardiac disease and has established itself as a technology leader. The company employs an expert staff of engineers and scientists, and proudly supports an extensive network of customers at universities, pharmaceutical companies and contract research organizations throughout the world.

3397 White Oak, Rd. Unit #3
London, Ontario
N6E3A1
Canada
Tel: 519.680.7677
Fax:519.680.7718

This release was published on openPR.